However, the widespread elevation of S100B in other neurological and neuropsychological disorders, such as Alzheimer’s disease and schizophrenia, in addition to the fact that elevated levels of S100B can arise from extracranial sources, raises concerns about its diagnostic accuracy and its specificity for stroke triage [33]. This evidence concerns the gene S100B and stroke disorder.